Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
S100 calcium binding protein A16 (S100A16) is expressed in various cancers; however, there are few reports on S100A16 in bladder cancer (BC). We retrospectively investigated clinical data including clinicopathological features in 121 patients with BC who underwent radical cystectomy (RC). Immunohist...
Main Authors: | Hiroki Katsumata, Kazumasa Matsumoto, Kengo Yanagita, Yuriko Shimizu, Shuhei Hirano, Kazuki Kitajima, Dai Koguchi, Masaomi Ikeda, Yuichi Sato, Masatsugu Iwamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14536 |
Similar Items
-
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
by: Dai Koguchi, et al.
Published: (2021-04-01) -
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer
by: Shuhei Hirano, et al.
Published: (2022-05-01) -
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
by: Kohei Mori, et al.
Published: (2022-03-01) -
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
by: Soichiro Shimura, et al.
Published: (2021-10-01) -
Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study
by: Dai Koguchi, et al.
Published: (2022-05-01)